{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:14:39Z","timestamp":1784657679134,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T00:00:00Z","timestamp":1383091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00520-013-2012-3","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T11:11:27Z","timestamp":1383045087000},"page":"603-610","source":"Crossref","is-referenced-by-count":63,"title":["Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients"],"prefix":"10.1007","volume":"22","author":[{"given":"Marta","family":"Bodro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fe","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Contra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Boix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Domingo-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,30]]},"reference":[{"issue":"2","key":"2012_CR1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","volume":"49","author":"CI Kang","year":"2005","unstructured":"Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW (2005) Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49(2):760\u2013766","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2012_CR2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60(5):913\u2013920","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2012_CR3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.01169-07","volume":"52","author":"CG Giske","year":"2008","unstructured":"Giske CG, Monnet DL, Cars O, Carmeli Y (2008) Clinical and economic impact of common multidrug-resistant Gram-negative bacilli. Antimicrob Agents Chemother 52(3):813\u2013821","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"2012_CR4","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1086\/590062","volume":"47","author":"DL Paterson","year":"2008","unstructured":"Paterson DL (2008) Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis 47(Suppl 1):S14\u2013S20","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2012_CR5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s101560050031","volume":"5","author":"S Spanik","year":"1999","unstructured":"Spanik S, Krupova I, Trupl J, Kunova A, Novotny J, Mateicka F, Pichnova E, Sulcova M, Sabo A, Jurga L, Krcmery JVV (1999) Bacteremia due to multiresistant Gram-negative bacilli in neutropenic cancer patients: a case-controlled study. J Infect Chemother 5(3):180\u2013184","journal-title":"J Infect Chemother"},{"issue":"Suppl 1","key":"2012_CR6","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/383048","volume":"39","author":"R Ramphal","year":"2004","unstructured":"Ramphal R (2004) Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39(Suppl 1):S25\u2013S31","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2012_CR7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ijantimicag.2008.06.017","volume":"32","author":"R Feld","year":"2008","unstructured":"Feld R (2008) Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 32(Suppl 1):S30\u2013S33","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"2012_CR8","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30","author":"J Klastersky","year":"2007","unstructured":"Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmans M (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51\u2013S59","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"2012_CR9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s100960050345","volume":"18","author":"E Gonzalez-Barca","year":"1999","unstructured":"Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Salar A, Peris J, Granena A, Gudiol F (1999) Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 18(8):539\u2013544","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"2012_CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice LB (2008) Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197(8):1079\u20131081","journal-title":"J Infect Dis"},{"issue":"1","key":"2012_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis 48(1):1\u201312","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2012_CR12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1378\/chest.11-0462","volume":"140","author":"A Sandiumenge","year":"2011","unstructured":"Sandiumenge A, Lisboa T, Gomez F, Hernandez P, Canadell L, Rello J (2011) Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE Organisms. Chest 140(3):643\u2013651","journal-title":"Chest"},{"issue":"3","key":"2012_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jac\/dks512","volume":"68","author":"EJ Bow","year":"2013","unstructured":"Bow EJ (2013) There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy. J Antimicrob Chemother 68(3):492\u2013495","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2012_CR14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/319600","volume":"32","author":"AD Harris","year":"2001","unstructured":"Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case\u2013control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32(7):1055\u20131061","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2012_CR15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791\u2013797","journal-title":"Ann Intern Med"},{"issue":"16","key":"2012_CR16","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J (2000) The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038\u20133051","journal-title":"J Clin Oncol"},{"key":"2012_CR17","unstructured":"Clinical and Laboratory Sandards Institute (formery NCCLS). Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. CLSI document M100-S22 (ISBN 1-56238-785-5)"},{"issue":"10","key":"2012_CR18","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JCM.41.10.4623-4629.2003","volume":"41","author":"K Lee","year":"2003","unstructured":"Lee K, Lim YS, Yong D, Yum JH, Chong Y (2003) Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41(10):4623\u20134629","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2012_CR19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","volume":"66","author":"C Gudiol","year":"2011","unstructured":"Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sanchez-Ortega I, Duarte R, Calvo M, Carratala J (2011) Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 66(3):657\u2013663","journal-title":"J Antimicrob Chemother"},{"key":"2012_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-8-80","volume":"8","author":"S Irfan","year":"2008","unstructured":"Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R (2008) Emergence of carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis 8:80","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2012_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cncr.21115","volume":"104","author":"N Ohmagari","year":"2005","unstructured":"Ohmagari N, Hanna H, Graviss L, Hackett B, Perego C, Gonzalez V, Dvorak T, Hogan H, Hachem R, Rolston K, Raad I (2005) Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 104(1):205\u2013212","journal-title":"Cancer"},{"issue":"3","key":"2012_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0100-879X2009000300010","volume":"42","author":"M Garnica","year":"2009","unstructured":"Garnica M, Maiolino A, Nucci M (2009) Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients. Braz J Med Biol Res 42(3):289\u2013293","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"2012_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","volume":"58","author":"EM Trecarichi","year":"2009","unstructured":"Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L (2009) Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58(4):299\u2013307","journal-title":"J Infect"},{"issue":"12","key":"2012_CR24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1705677","volume":"39","author":"AL Oliveira","year":"2007","unstructured":"Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, Simoes BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M (2007) Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 39(12):775\u2013781","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2012_CR25","first-page":"1102","volume":"90","author":"C Cordonnier","year":"2005","unstructured":"Cordonnier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G, Bastuji-Garin S (2005) Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica 90(8):1102\u20131109","journal-title":"Haematologica"},{"issue":"5","key":"2012_CR26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","volume":"19","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, Bodro M, Simonetti A, Tubau F, Gonzalez-Barca E, Cisnal M, Domingo-Domenech E, Jimenez L, Carratala J (2013) Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 19(5):474\u2013479. doi: 10.1111\/j.1469-0691.2012.03879.x","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"2012_CR27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","volume":"65","author":"C Gudiol","year":"2010","unstructured":"Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratala J, Gudiol F (2010) Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother 65(2):333\u2013341","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2012_CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jmii.2010.08.004","volume":"44","author":"SS Wang","year":"2011","unstructured":"Wang SS, Lee NY, Hsueh PR, Huang WH, Tsui KC, Lee HC, Wu CJ, Chang CM, Huang CC, Huang CF, Ko WC (2011) Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect 44(4):282\u2013288","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"2012_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","volume":"91","author":"CI Kang","year":"2012","unstructured":"Kang CI, Chung DR, Ko KS, Peck KR, Song JH (2012) Risk factors for infection and treatment outcome of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 91(1):115\u2013121","journal-title":"Ann Hematol"},{"issue":"4","key":"2012_CR30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/cncr.24812","volume":"116","author":"G Rangaraj","year":"2010","unstructured":"Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I (2010) Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116(4):967\u2013973","journal-title":"Cancer"},{"issue":"9","key":"2012_CR31","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3201\/eid1209.060397","volume":"12","author":"L LeBlanc","year":"2006","unstructured":"LeBlanc L, Pepin J, Toulouse K, Ouellette MF, Coulombe MA, Corriveau MP, Alary ME (2006) Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 12(9):1398\u20131405","journal-title":"Emerg Infect Dis"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-2012-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-2012-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-2012-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T12:20:18Z","timestamp":1564575618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-2012-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,30]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-2012-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,30]]}}}